Not enough adults are getting the recommended screening tests for colorectal, breast, and cervical cancers, the Centers for Disease Control and Prevention (CDC) has reported.
Abbott announced that the Food and Drug Administration (FDA) has granted clearance for the i-STAT Total β-hCG blood test to detect if a woman is in the early stages of pregnancy.
Women in their 40s should talk with their doctors and then decide for themselves whether they need regular mammograms to screen for breast cancer before age 50, according to draft U.S. federal health guidelines.
Ultrasound is more cost-effective and safer than other imaging technologies for imaging the female pelvis and should be the first modality used for patients with pelvic symptoms, advocates of the American Institute of Ultrasound in Medicine (AIUM) have proposed.
Nearly all emergency department doctors recently surveyed said they order magnetic resonance imaging or computed tomography scans their patients may not need, mainly because they fear malpractice lawsuits.
Auxogyn announced the availability of the Eeva Test to help the embryo selection process by taking images of the embryos during the incubation period. The Eeva Test is a first-in-class, noninvasive predictive test to aid clinicians during in vitro fertilization (IVF).
Navidea announced that the Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Lymphoseek (technetium Tc 99m tilmanocept) injection.
Kinsa Health announced the availability of the Kinsa Smart Thermometer, the first FDA-cleared smartphone-connected thermometer and health tracking app.